Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features

A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention

(2013) Roland Rad et al.   CANCER CELL

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

(2013) Frank A. Sinicrope et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer

(2013) Eva Budinska et al.   JOURNAL OF PATHOLOGY

Replication stress links structural and numerical cancer chromosomal instability

(2013) Rebecca A. Burrell et al.   NATURE

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

(2013) Felipe De Sousa E Melo et al.   NATURE MEDICINE

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

(2013) Anguraj Sadanandam et al.   NATURE MEDICINE

Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value

(2013) Laetitia Marisa et al.   PLOS MEDICINE

The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

(2012) Anne E. Powell et al.   CELL

Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum

(2012) Mai Yamauchi et al.   GUT

Identification of a Poor-PrognosisBRAF-Mutant–Like Population of Patients With Colon Cancer

(2012) Vlad Popovici et al.   JOURNAL OF CLINICAL ONCOLOGY

A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency

(2012) Sun Tian et al.   JOURNAL OF PATHOLOGY

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations

(2012) Tao Xie et al.   PLoS One

Gene Expression Differences between Colon and Rectum Tumors

(2011) R. Sanz-Pamplona et al.   CLINICAL CANCER RESEARCH

Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival

(2011) Frank Benedix et al.   DISEASES OF THE COLON & RECTUM

Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data

(2011) Jennifer M. Weiss et al.   JOURNAL OF CLINICAL ONCOLOGY

Update on the serrated pathway to colorectal carcinoma

(2010) Dale C. Snover   HUMAN PATHOLOGY

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

(2010) Wendy De Roock et al.   LANCET ONCOLOGY

Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial

(2009) F. T. Bosman et al.   CLINICAL CANCER RESEARCH

Translational up-regulation of Aurora-A in EGFR-overexpressed cancer

(2009) Chien-Hsien Lai et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?

(2008) Robert A. Meguid et al.   ANNALS OF SURGICAL ONCOLOGY

Map of differential transcript expression in the normal human large intestine

(2007) Lawrence C. LaPointe et al.   PHYSIOLOGICAL GENOMICS